 Nov 1 2022
Recent article published in Molecular Oncology with MedRod® implants i...
|
 |
| PRICE QUOTE AND TECHNICAL INQUIRIES |
FOLLOW US
 |
|
|
Progesterone For mice and rats in metabolic and breast cancer xenograft, PDX and syngeneic studiesProgesterone (P4) implants for preclinical in vivo studies.
Drug release: 50 – 150 days
Dose range: 25 µg – 250 µg/day
|  | |
|
